MacDonald ME, Ambrose CM, Duyao MP et al (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington’s disease chromosomes. Cell 72:971–983. https://doi.org/10.1016/0092-8674(93)90585-E

Article  Google Scholar 

Landles C, Sathasivam K, Weiss A et al (2010) Proteolysis of mutant Huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in huntington disease. J Biol Chem 285:8808–8823. https://doi.org/10.1074/jbc.M109.075028

Article  CAS  PubMed  PubMed Central  Google Scholar 

DiFiglia M, Sapp E, Chase KO et al (1997) Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Sci (80-) 277:1990–1993. https://doi.org/10.1126/science.277.5334.1990

Article  CAS  Google Scholar 

Shirendeb U, Reddy AP, Manczak M et al (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant Huntingtin oligomers in huntington’s disease: implications for selective neuronal damage. Hum Mol Genet 20:1438–1455. https://doi.org/10.1093/hmg/ddr024

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Standley C, Sapp E et al (2009) Mutant Huntingtin impairs vesicle formation from recycling endosomes by interfering with Rab11 activity. Mol Cell Biol 29:6106–6116. https://doi.org/10.1128/mcb.00420-09

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhai W, Jeong H, Cui L et al (2005) In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets. Cell 123:1241–1253. https://doi.org/10.1016/j.cell.2005.10.030

Article  CAS  PubMed  Google Scholar 

Jin YN, Johnson GVW (2010) The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in huntington disease. J Bioenerg Biomembr 42:199–205

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim J, Moody JP, Edgerly CK et al (2010) Mitochondrial loss, dysfunction and altered dynamics in huntington’s disease. Hum Mol Genet 19:3919–3935. https://doi.org/10.1093/hmg/ddq306

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galimberti M, Nucera MR, Bocchi VD et al (2024) Huntington ’ s disease cellular phenotypes are rescued non-cell autonomously by healthy cells in mosaic telencephalic organoids. Nat Commun 15:6534. https://doi.org/10.1038/s41467-024-50877-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goedert M, Eisenberg DS, Crowther RA (2017) Propagation of Tau aggregates and neurodegeneration. Annu Rev Neurosci 40:189–210. https://doi.org/10.1146/annurev-neuro-072116-031153

Article  CAS  PubMed  Google Scholar 

Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic parkinson’s disease. Neurobiol Aging 24:197–211. https://doi.org/10.1016/S0197-4580(02)00065-9

Article  PubMed  Google Scholar 

Grad LI, Yerbury JJ, Turner BJ et al (2014) Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 111:3620–3625. https://doi.org/10.1073/pnas.1312245111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95:13363–13383. https://doi.org/10.1073/pnas.95.23.13363

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cicchetti F, Lacroix S, Cisbani G et al (2014) Mutant Huntingtin is present in neuronal grafts in huntington disease patients. Ann Neurol 76:31–42. https://doi.org/10.1002/ana.24174

Article  CAS  PubMed  Google Scholar 

Pecho-Vrieseling E, Rieker C, Fuchs S et al (2014) Transneuronal propagation of mutant Huntingtin contributes to non-cell autonomous pathology in neurons. Nat Neurosci 17:1064–1072. https://doi.org/10.1038/nn.3761

Article  CAS  PubMed  Google Scholar 

Babcock DT, Ganetzky B (2015) Transcellular spreading of Huntingtin aggregates in the drosophila brain. Proc Natl Acad Sci U S A 112:E5427–E5433. https://doi.org/10.1073/pnas.1516217112

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jansen AHP, Batenburg KL, Pecho-Vrieseling E, Reits EA (2017) Visualization of prion-like transfer in Huntingtons disease models. BBA Mol Basis Dis 1863:793–800. https://doi.org/10.1016/j.bbadis.2016.12.015

Article  CAS  Google Scholar 

Jeon I, Cicchetti F, Cisbani G et al (2016) Human-to-mouse prion-like propagation of mutant Huntingtin protein. Acta Neuropathol 132:577–592. https://doi.org/10.1007/s00401-016-1582-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan Z, Dai W, Van Erp TGM et al (2015) Huntington’s disease cerebrospinal fluid seeds aggregation of mutant Huntingtin. Mol Psychiatry 20:1286–1293. https://doi.org/10.1038/mp.2015.81

Article  CAS  PubMed  PubMed Central  Google Scholar 

Björkqvist M, Wild EJ, Thiele J et al (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in huntington’s disease. J Exp Med 205:1869–1877. https://doi.org/10.1084/jem.20080178

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schwab C, Klegeris A, Mcgeer PL (2010) Inflammation in transgenic mouse models of neurodegenerative disorders. BBA Mol Basis Dis 1802:889–902. https://doi.org/10.1016/j.bbadis.2009.10.013

Article  CAS  Google Scholar 

Ellrichmann G, Reick C, Saft C, Linker RA (2018) The role of the immune system in Huntington’s disease. Clin Exp Immunol 192:142–150. https://doi.org/10.1111/cei.13119

Article  Google Scholar 

Dash D, Mestre TA (2020) Therapeutic update on huntington’s disease: symptomatic treatments and emerging Disease-Modifying therapies. Neurother J Am Soc Exp Neurother 17:1645–1659. https://doi.org/10.1007/s13311-020-00891-w

Article  Google Scholar 

Hu J, Matsui M, Corey DR (2009) Allele-selective inhibition of mutant huntingtin by peptide nucleic acid (PNA)-peptide conjugates, locked nucleic acid (LNA), and SiRNA. Ann N Y Acad Sci 1175:24–31 https://doi.org/10.1111/j.1749-6632.2009.04975.x.Allele-Selective

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Ho L, Qin W et al (2005) Caloric restriction attenuates β-amyloid neuropathology in a mouse model of Alzheimer’s disease. FASEB J 19:1–18. https://doi.org/10.1096/fj.04-3182fje

Article  CAS  PubMed  Google Scholar 

Chang P, Augustin K, Boddum K et al (2016) Seizure control by decanoic acid through direct AMPA receptor Inhibition. Brain 139:431–443. https://doi.org/10.1093/brain/awv325

Article  PubMed  Google Scholar 

Andersen JV, Westi EW, Jakobsen E et al (2021) Astrocyte metabolism of the medium-chain fatty acids octanoic acid and decanoic acid promotes GABA synthesis in neurons via elevated glutamine supply. Mol Brain 14:132. https://doi.org/10.1186/s13041-021-00842-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanguanphun T, Sornkaew N, Malaiwong N et al (2022) Neuroprotective effects of a medium chain fatty acid, decanoic acid, isolated from H. leucospilota against parkinsonism in C. elegans PD model. Front Pharmacol 13:1–17. https://doi.org/10.3389/fphar.2022.1004568

Article  CAS